FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to a medicinal formulation consisting of a core comprising the following components, wt.-%: trimetazidine dihydrochloride, 9.0-32.0; hydroxypropylcellulose, 3.0-10.5; hydroxyethylcellulose, 18.5-67.2; sodium alginate, 0.1-0.6; calcium phosphate dihydrate, 19.0-28.5; magnesium stearate, 0.5-2.0; talc, 0.5-2.0, and envelope comprising the following components, wt.-%: one component chosen from the group including hydroxypropylcellulose, water-soluble methylcellulose or hydroxypropylcellulose, 0.6-2.7; Tween-80, 0.3-1.2; pigment titanium dioxide, 0.1-1.0 and red iron oxide, 0.1-0.8. Method for preparing the medicinal formulation is carried out by wet granulation, tabletting prepared granules and applying the envelope from an aqueous suspension by spraying preferably. Release of trimetazidine dihydrochloride in the body from the new proposed formulation is carried out for 8 h that provides the constant level of the preparation in blood.
EFFECT: improved preparing method, valuable pharmaceutical properties of formulation.
3 cl, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PROLONGED PHARMACEUTICAL COMPOSITION DRUG FORM AND METHOD OF ITS PRODUCTION (VERSIONS) | 2009 |
|
RU2435584C2 |
MODIFIED RELEASE DOSAGE FORM OF TRIMETAZIDINE DIHYDROCHLORIDE | 2009 |
|
RU2412706C1 |
MATRIX TABLET WITH BASIS FOR TRIMETAZIDINE DIHYDROCHLORIDE RELEASE, WAY OF ITS RECEPTION AND WAY OF TREATMENT | 2007 |
|
RU2362548C1 |
MEDICINAL FORMULATION ELICITING BACTERIOSTATIC EFFECT AND METHOD FOR IT PREPARING | 2003 |
|
RU2240112C1 |
METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
MEDICINAL FORMULATION ELICITING ANTI-ANGINAL EFFECT AND METHOD FOR ITS PREPARING | 2003 |
|
RU2260431C2 |
PHARMACEUTICAL COMPOSITION EXHIBITING CARDIOVASCULAR EFFECT | 1999 |
|
RU2145214C1 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTITUBERCULOSIS EFFECT | 2005 |
|
RU2280451C1 |
MODIFIED RELEASE DOSAGE FORM OF TRIMETHAZIDIN AND METHOD FOR PREPARING THEREOF (VERSIONS) | 2008 |
|
RU2410097C2 |
PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
Authors
Dates
2006-08-20—Published
2005-02-14—Filed